Detalhe da pesquisa
1.
Association of ABC and RENAL Scoring Systems With Morbidity in Partial Nephrectomy.
Anticancer Res
; 42(12): 6057-6062, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36456124
2.
Treatment of Metastatic Castration-resistant Prostate Cancer Patients With Abiraterone Acetate and Prednisone and Corresponding Survival Prognostic Factors.
Anticancer Res
; 41(8): 3955-3968, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34281859
3.
[Prolonged hypogonadism after cessation of androgen deprivation therapy for prostate cancer]. / Hipogonadismo prolongado tras la suspensión de tratamiento hormonal en pacientes con cáncer de próstata.
Actas Urol Esp
; 33(7): 747-54, 2009.
Artigo
em Espanhol
| MEDLINE | ID: mdl-19757659
4.
Serum biomarkers of inflammation for diagnosis of prostate cancer in patients with nonspecific elevations of serum prostate specific antigen levels.
Transl Cancer Res
; 8(1): 273-278, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35116756
5.
Radium 223 combined with new hormone therapies for the treatment of castrate-resistant metastatic prostate cancer: scientific evidence and sharing of our experience.
Transl Androl Urol
; 8(5): 567-573, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31807434
6.
Predictive Factors of Renal Function in Partial Laparoscopic Nephrectomy in Patients with a Kidney Tumor.
Curr Urol
; 13(3): 150-156, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31933594
7.
Hipogonadismo prolongado tras la suspensión de tratamiento hormonal en pacientes con cáncer de próstata / Prolonged hypogonadism after cessation of androgen deprivation therapy for prostate cancer
Actas urol. esp
; 33(7): 747-754, jul.-ago. 2009. graf, tab
Artigo
em Espanhol
| IBECS (Espanha) | ID: ibc-75074